TABLE 1.
Variable description | Baseline value | Reference(s) |
---|---|---|
Protection from reinfection in latent infection state | 0.5 | 41, 42 |
Proportion progressing rapidly to active TB | 0.15 | 43 |
Baseline life expectancy (yr) | 70 | 44 |
TB-specific mortality rate/yr | 0.17 | 45 |
Probability of endogenous reactivation over the patient's lifetime | 5% | 46 |
Rate of diagnosis and treatment initiation/yr | 0.69 | 21 |
Relative infectiousness of patients on ineffective treatment | 0.2 | 47 |
Rate of spontaneous recovery from active TB/yr | 0.17 | 45 |
% discontinuing treatment prior to completion | ||
First-line treatment | 6 | 21 |
Second-line treatment | 23 | 35 |
% experiencing early relapse | ||
Drug-sensitive TB | 4 | 48, 49 |
RIF-resistant TB | 16 | 50 |
FQ-resistant TB | 12 | 50 |
PZA-resistant TB | 8 | 14 |
Additional details are provided in Table S3 in the supplemental material.